RhythmAnalytics vs KardiaAI

Direct competitors — feature-level head-to-head below. Comparability 90/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Biofourmis Singapore Pte.
VS
by AliveCor

AI Verdict

Both RhythmAnalytics and KardiaAI are FDA-cleared, AI-powered solutions for interpreting cardiac arrhythmias from ECG data, offering clinical decision support. RhythmAnalytics provides a broader range of detailed ECG signal processing and beat-by-beat morphology analysis via a cloud-based API, suitable for integration with various FDA-cleared ECG devices. KardiaAI, as an AI software library, focuses on detecting specific cardiac conditions and rhythm variations, emphasizing integration into mobile and web platforms for ambulatory ECG analysis.

Choose RhythmAnalytics if…

Choose RhythmAnalytics if your organization requires a comprehensive, AI-powered cloud-based solution for automated, detailed interpretation of a wide range of cardiac arrhythmias from various single-lead ECG devices. This tool is ideal for healthcare professionals seeking robust clinical decision support with beat-by-beat morphology computation and detection of over 15 arrhythmia types, easily integrated via a cloud-based API.

View RhythmAnalytics →

Choose KardiaAI if…

Choose KardiaAI if you are an integrator looking for an FDA-cleared AI software library to embed medical-grade ECG analysis capabilities directly into your mobile applications or web platforms for ambulatory rhythm monitoring. This solution is best suited for detecting common cardiac conditions like AFib, bradycardia, tachycardia, and specific sinus rhythm variations with PVCs or SVE, offering a subscription-based model for integrated services.

View KardiaAI →

When choosing between RhythmAnalytics by Biofourmis and KardiaAI by AliveCor, physicians should consider their primary need for arrhythmia detection and integration capabilities. RhythmAnalytics excels in comprehensive, automated interpretation of cardiac arrhythmias from single-lead ECG data, identifying over 15 types, including AFib, ventricular arrhythmias, and ectopic beats. Its cloud-based API is designed for seamless integration with existing FDA-cleared ECG devices, making it suitable for healthcare professionals and integrators seeking a broad spectrum of arrhythmia analysis and clinical decision support within their current workflows.

In contrast, KardiaAI offers an AI software library focused on detecting specific cardiac conditions like AFib, bradycardia, tachycardia, and various sinus rhythms with ectopy. Its deployment as a Software as a Medical Device (SaMD) and API library, often integrated into mobile apps and web platforms, suggests a more direct-to-provider or patient-facing application, particularly with its subscription-based pricing for integrated services like KardiaCare. The key practical difference lies in RhythmAnalytics’ broader, automated interpretation capabilities versus KardiaAI’s more focused detection library. Physicians prioritizing extensive, automated arrhythmia analysis across diverse ECG data sources for clinical decision support may find RhythmAnalytics more aligned with their needs. Those seeking a more targeted AI solution for specific rhythm detections, potentially for integration into mobile or web-based platforms, might prefer KardiaAI.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature RhythmAnalytics KardiaAI
Pricing Contact vendor Subscription-based for integrated services
Deployment Cloud-based API Software as a Medical Device (SaMD), API library integrated into mobile apps and web platforms
FDA Status 1 AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

KardiaAI

KardiaAI (Tool B) is part of an ecosystem that includes consumer-facing devices and apps, with transparent pricing for integrated services (KardiaCare), suggesting a strong focus on end-user experience and accessibility. RhythmAnalytics (Tool A) is primarily a cloud-based API, indicating its direct usability is for developers and integrators, not directly for clinicians or patients.

Clinical Value

RhythmAnalytics

RhythmAnalytics (Tool A) explicitly states detection of 'over 15 types of cardiac arrhythmias' and offers 'beat-by-beat morphology computation,' suggesting a more comprehensive and granular level of analysis. While KardiaAI (Tool B) detects several key conditions, Tool A's broader and deeper analytical capabilities indicate higher clinical value in terms of diagnostic depth.

Pricing & Value

KardiaAI

KardiaAI (Tool B) provides transparent, tiered pricing for its integrated services (KardiaCare), allowing potential users to clearly understand the cost and value proposition. RhythmAnalytics (Tool A) requires contacting the vendor for pricing, making it impossible to assess its value without further inquiry.

Enterprise Readiness

KardiaAI

KardiaAI (Tool B) explicitly confirms having a Business Associate Agreement (BAA), which is a critical requirement for enterprise healthcare deployments handling Protected Health Information (PHI). RhythmAnalytics (Tool A) lists its BAA status as unspecified, which could be a significant barrier for enterprise adoption. Both are FDA-cleared and HIPAA compliant.

Innovation

RhythmAnalytics

RhythmAnalytics (Tool A) highlights 'beat-by-beat morphology computation' and the detection of 'over 15 types of cardiac arrhythmias,' which suggests a potentially more advanced and comprehensive analytical engine. While KardiaAI (Tool B) is innovative in its application, Tool A's described capabilities indicate a deeper level of algorithmic innovation in ECG analysis.

Support & Docs

KardiaAI

AliveCor (Tool B) has a well-established developer program with public-facing SDKs and APIs, and extensive documentation for integrating its technology, as evidenced by its developer resources. Biofourmis (Tool A), while a large company, does not have as readily accessible public developer documentation for RhythmAnalytics, implying that support and documentation might be less transparent or require direct engagement.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature RhythmAnalytics KardiaAI
Name RhythmAnalytics KardiaAI
Company Biofourmis Singapore Pte. AliveCor
Description FDA-cleared, AI-powered cloud-based software that provides automated interpretation of cardiac arrhythmias from single-lead ECG data, offering clinical decision support for healthcare professionals and integrators. FDA-cleared AI software library for analyzing ambulatory ECG rhythms, detecting various cardiac conditions like AFib, bradycardia, and tachycardia.
Key Features (Examples) AI-based automated interpretation of cardiac arrhythmias; Detection of over 15 types of cardiac arrhythmias (including AFib, ventricular arrhythmias, ectopic beats); Beat-by-beat morphology computation AI-powered ECG analysis library; Detection of atrial fibrillation, bradycardia, tachycardia, and normal sinus rhythm; Detection of Sinus Rhythm with Premature Ventricular Contractions (PVCs)

Videos

Demos, reviews, and walkthroughs featuring RhythmAnalytics and KardiaAI.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

RhythmAnalytics is FDA-cleared to detect over 15 types of cardiac arrhythmias, including AFib, ventricular arrhythmias, and ectopic beats, with beat-by-beat morphology computation. KardiaAI detects atrial fibrillation, bradycardia, tachycardia, and normal sinus rhythm. It also offers advanced determinations for Sinus Rhythm with Premature Ventricular Contractions (PVCs), Sinus Rhythm with Wide QRS, and Sinus Rhythm with Supraventricular Ectopy (SVE).
RhythmAnalytics is a cloud-based API designed for integration into existing cardiac monitoring solutions or directly into medical devices and wearable sensors. KardiaAI is an API library deployed as Software as a Medical Device (SaMD), intended for integration into mobile apps and web platforms, and compatible with ambulatory ECG devices.
RhythmAnalytics is compatible with single-lead ECG data from FDA-cleared ECG devices, including Holter monitors, event recorders, and wearable sensors. KardiaAI is designed to analyze ambulatory ECG rhythms from adult subjects, supporting data recorded in compatible formats from various ambulatory ECG devices like event recorders.
Yes, RhythmAnalytics offers beat-by-beat morphology computation, ECG signal processing and analysis, QRS and Ventricular Ectopic Beat detection, and QRS feature extraction with interval and heart rate measurement. KardiaAI includes ECG noise filtering and noisy ECG detection, in addition to its rhythm analysis capabilities.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.